Showing posts with label SGO Annual meeting. Show all posts
Showing posts with label SGO Annual meeting. Show all posts

Monday, March 17, 2025

From a Distance: SGO Annual Meeting 2025 - Ovarian Cancer Highlights

I was unable to attend the SGO Annual meeting this year due to a family commitment but I did follow along on X(Twitter).

To kept on top of the action, I followed SGO Social Media Ambassadors Social Media Ambassadors on X- @RiosDoriaMD , @nicoleflemingmd, @meddles28, and @ShannonWestin and others.

Here are some of their ovarian cancer research posts I found most interesting :

Trop-2 is a cell surface protein expressed by cancer cells 
ADC Antibody Drug Conjugate 
Stomatitis is inflammation of the mucous membranes of the mouth . 
58 patients in the study
 
GOG 3066/DENALI 
Azenosertib an enzyme inhibitor that binds to called Wee1 and disrupt cell reproduction. 
Cyclin E1 is a protein is encoded by the CCNE1 gene.

 

 GOG 3044
Afuresertib inhibitor of the serine/threonine protein kinase Akt (protein kinase B) . No significant difference in progression free or overall survival.

 


EWOC-1 was a study of three different chemotherapy regimens . Use of carboplatin alone was associated with poorer survival.

 

 Mirv MIRASOL Study of ocular events.

RAINFOL-01 study (NCT05579366)  

Rinatabart sesutecan (Rina-S) a novel folate receptor alpha (FRα)–targeted antibody-drug conjugate (ADC). The treatment in  heavily pretreated patients with platinum-resistant ovarian cancer  showed activity regardless of folate receptor alpha (FRα) expression level.

 Low Grade Serous Ovarian Cancer 

Combo of Avutometinib  a Ras-Raf-MEK-ERK signaling inhibitor and Defactinib is small molecule inhibtor of focal adhesion kinase (FAK) for KRAS + recurrent low grade OC.

Please let me know if I missed anything you felt was important for patients/ survivors. 

 I was happy to see ways that patient advocates, researchers and clinicians were able to   #MultiplyYourImpact ! 

Thank you Dr Fader (@amandanfader)  for your leadership!  I look forward to your vision for the future,  Dr Karen Lu (@karenluMD) !

Dee

Every Day is a Blessing! 

Posted by at No comments:
Labels: , , , , , , , , , ,

Tuesday, March 19, 2024

2024 Annual SGO Meeting Monday March 18, 2024


This was the final day of the 2024 SGO meeting.

I caught the tail end of the SGO Business meeting which included the passing of the gavel from this years President , Dr Angeles Alvarez-Secord to Dr Amanda Fader.

 

The next session, Doctor as Patient:Michael Frumovitz, MD,MPH,MS,CPXP was a moving presentation. Dr Frumovitz shared with his medical colleagues what his experience was as physician and  stage 3 pancreatic cancer patient. He mentioned how cancer patients run the gamut from those who are private to those who are public about their experiences.  


 
 
 
The Rapid Fire Poster Optimizing Surgery, Recovery and Survivorship followed.
 
Endometrial Cancer Assessment

 

 

 Heated IP chemotherapy (HIPEC)  during interval cytoreductive survery was associated with imporved survival.

 Criteria to determine need for ileostomy. 

Comparison of 2 drugs used to prevent venous thrombosis. 

Using Text messaging to measure PRO. 

Barriers to fertility preservation

Memory Impairment in post menopausal women was associated with increased age and comorbidity not chemotherapy. 

Another advocate presentation on peer support for Black women with endometrial cancer.  

 

The Fireside Chat: Critical Issues in Gyn Cancers and the Power of Shared Purpose panel included representatives from other gynecologic cancer organizations. They see the need to work together in many areas including improving recruitment of underrepresented peoples to clinical trials. I was pleased to see Annie Ellis, Patient Advocate and Survivor approach the mic at the end and share her thoughts. 

There was a moving tribute to former SGO President , Dr Wendy Brewster who passed away from pancreatic cancer. 

 Dr Secord gave her Presidential address. She certainly helped to grow SGO with now over 3000 members. 

 

Poster session 2 included the abstract that survivor/advocates Annie Ellis, Lynda Ryan, Adrienne Moore and I , submitted.   It was so exciting to have our abstract accepted for this poster session.


The final session I attended was Scientific Plenary V Late Breaking Abstract Session 2 .

Endometrial Cancer  

Another Patient presenting her experience in the DUO trial.

Ovarian Cancer Duo trial using Durvalumab , Bev and Olaparib

Chinese study of Niraparib maintenance and Individualized Dosing

The use of a P-53 reactivator in a PH 1 trial. 

 

Thanks SGO,  especially Dr Pothuri, Dr Powell and the entire planning committee for such a well run and informative meeting. Thanks again for going our of your way to including so many survivor-advocates in  important meeting presentations, on panels and presenting their posters.

Hope to see you next year in Seattle. 

Dee

Every Day is a Blessing! 

Posted by at No comments:
Labels: , , , , , , , , , , , , ,

Monday, March 18, 2024

2024 SGO Annual Meeting Saturday March 16th Session Review


 

I virtually attended five sessions on day one of the SGO Annual Meeting -  the Opening Ceremony, News We Can All use (Plenary), Moving the Needle (Plenary), Science to Drive Purpose(Plenary)  and Together We Tackle Cancer Rapid Fire Poster Sessions. (Saturday March 16,2024.)

Please be patient while reading this post since it may take some time for all the X posts and photos to download. 

I'm going to start this post by giving a shout out to the patients and advocates involved in presenting on Saturday.  Check out Susan, Linda, Shawn and Jennifer!

Here are just a few of the 60 tweets & retweets I shared during the Saturday meeting.  

Endometrial Cancer

Ovarian Cancer 

HER -2 Expressing Tumors 

Cervical Cancer

Ovarian Cancer 

Endometrial Cancer

Ovarian Cancer

 Recurrent Endometrial, Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer

Endometrial Cancer

Together We Tackle Cancer Session:

I'll keep you updated on what I learned on Sunday and Monday in the next few days.   


Dee 

Every Day is a Blessing!

Posted by at No comments:
Labels: , , , , , , ,

Tuesday, March 12, 2024

Preparing For This Year's SGO Annual Meeting

I will be attending this year's SGO Annual Meeting virtually. It is being held in San Diego, March 15-March 18, 2024. On Friday, March 15th the 2024 Patient and Advocate Education Forum will also be held, in San Diego. The Forum is sponsored by the Foundation for Women's Cancer. I attended last year's forum and it was informative and allowed time to network with other patients , advocates and caregivers.

 


 

I received the link to the meeting app today so I started making my schedule and looking at sessions I'm interested in listening to. I will be posting on X using the #gyncsm from the sessions that occur in the main hall (F) as they occur live. Other segments of the meeting will be available for me to look at online after they are held and I will catch up on those after the meeting. 

I am happy to see many sessions include patient advocates including my friend Susan Leighton, presenting on Effectiveness of “Survivors Teaching Students®”: A patient-centered experiential educational model of ovarian cancer for rising healthcare professionals.  Thanks SGO and FWC!

I am also pleased to share that an abstract that Annie Ellis, Adrienne Moore, Linda Ryan and I submitted will be presented during the poster session on Monday, March 18th (Hall GH). I'll share more about that poster titled

Do it!': Gynecologic cancer clinical trial participants' advice to others and perspectives

on the day it is presented.

Here are some of the sessions I look forward to listening to:

Saturday

Scientific Plenary I: News We Can All Use 
  • Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study
 
Scientific Plenary II: Moving the Needle Together  
  • Patient-Reported Outcome Results from Phase III MIRASOL Trial of mirvetuximab soravtansine vs. Investigator’s Choice of Chemotherapy in FRα Positive Platinum-resistant Ovarian Cancer 
  • Efficacy and safety of alpelisib plus olaparib versus chemotherapy among patients with platinum-resistant or refractory high-grade serous ovarian cancer without BRCA mutation: Primary analysis of the EPIK-O trial 
  •  A phase II/III study of cediranib and olaparib combination compared to cediranib or olaparib alone or standard of care chemotherapy, in platinum-resistant ovarian cancer (NRG-GY005)

Sunday

Presidential Invited Speaker: Erin Diehl: "F" Words at Work Supported by the Wellness Committee and N.E.D. 

Focused Plenary IV: CtDNA: Molecular Mirrors & Markers 

  • The Prognostic Value of Circulating Minimal Residual Disease in First-Line Treatment of Ovarian Cancer 
  • Utility of ctDNA as an early predictive biomarker of response to radiation in gynecologic malignancies 
  • Monitoring Minimal Residual Disease Using Circulating Tumor DNA in Patients Treated Long-Term with PARP Inhibitors for Ovarian Cancer 

Scientific Plenary IV: Late Breaking Abstract Session 1

  • Clinical activity of tazemetostat, an EZH2 inhibitor, among patients with advanced endometrioid endometrial cancer and ovarian clear cell carcinoma with and without ARID1A mutations (NRG-GY014)

Monday 

Doctor as a Patient: Michael M. Frumovitz, MD 

Tribute to Dr. Brewster – Stephanie Blank, MD, Amanda Nickles Fader, MD, S. Diane Yamada, MD, and Angeles Alvarez Secord, MD

Presidential Address: Angeles Alvarez-Secord, MD
 
Scientific Plenary V: Late Breaking Abstract Session 2 - The Turning Point Don't Be Left Out
 
 
Additional sessions I'll view online include those addressing disparities, ADCs( antibody drug conjugates), and clinical trial design. 
 
Now I just have to remember the three hour time difference so I don't miss any live sessions.

For those attending in person, please us #gyncsm in your posts on X so I can hear what you find valuable.  "See" you all next weekend.

Dee
Every Day is a Blessing!

 

Posted by at No comments:
Labels: , , , ,

Thursday, March 30, 2023

SGO Annual Mtg 2023 Highlights - Participation

I returned recently from an exciting and informative SGO Annual Meeting. Over the next few days I will highlight research results that I found most impactful to patients, survivors and caregivers.  This blog post will be on participation and will cover how other advocates and I  participated in the meeting. 

The Foundation for Women's Cancer held a Patient Education Forum on Friday. They presented information on ovarian, endometrial, cervical rare gynecologic cancers as well as information on exercise, advocacy  and other topics. Some survivors shared the story of diagnosis and treatment. The room was filled with survivors, caregivers and advocates as well as organizations that support women with gyn cancers. 

Later that evening advocates were invited to the Foundation for Women's Cancer reception. Advocates were able to meet each other as well as gyn oncs, researchers and leadership of the Foundation. 

Saturday was a busy day. As a member of the SGO Communication Committee, I had the opportunity to participate in the  Education Forum Media Readiness session. I was part of a role play session on how to use different techniques such as pivot, personalize, deflect,acknowledge, and broaden when being interviewed by the media. As an advocate I am asked to comment on new treatments or breaking news and the tips shared during the session were helpful to me.


During the very next session Annie Ellis, survivor and advocate, presented Long-term survivors speak: perspectives on progress, during a Scientific Plenary Session. Annie and I  held a roundtable Zoom meeting and also surveyed long term ovarian cancer survivors about progress,  patient needs, and what ovarian cancer survivors want their doctor to know. It was so exciting to see Annie present and to hear the applause and comments that followed!

 

 

If you have questions about our abstract, don't hesitate to reach out to me for further details. 

On Sunday, the  Patient Education Committee held a advocate poster walk in which advocates were able view posters and to listen and ask questions of the poster authors. We were also given the opportunity to vote for the  Patient Advocate Hope Award winner. It was wonderful to see so many early career clinicians and researchers present their research. 

 



 I'll continue my highlight blog posts over the next few days.


Dee
Every Day is a Blessing
Posted by at No comments:
Labels: , , , , , , , , ,

Sunday, March 19, 2023

SGO Meeting Preparations

 

 

Thanks to support from my Cancer Center, I am heading south to Tampa for the SGO Annual Meeting on Friday. The theme of the meeting is Patients | Purpose | Progress. I'm so excited to be meet up with other survivors/advocates and to learn from the researchers who are making advances to improve the care of patients diagnosed with a gynecologic cancer. 

When I arrive on Friday, barring any airline delays, I hope to attend at least part of the Patients and Advocates Education Forum and Luncheon. I have attended them in the past and have always found them beneficial. This is the first once to be held in person since Covid began. 

Saturday, March 25th, will be an especially busy day for me. 

As a member of the SGO Communications Committee I will be part of a presentation on Saturday ( 2:45pm Ballroom A) . This Education Forum, Ready for Primetime: Media Readiness will present strategies of how to best respond and state your position when asked questions by the media.  

Following the Forum, the Scientific Plenary II session (East Hall, 4pm) will take place.  Survivor/advocate, Annie Ellis, will be presenting Long-term survivors speak: patient perspectives on progress, an abstract she and I co-authored. I will share more about the abstract after the meeting.

There are a number of other sessions I am looking forward to attending and am busy working on the app to set up my schedule and work in some time to meet up with some of my gyn onc friends. 

On Twitter,  be sure to follow the hashtags #SGOmtg and #gyncsm for news from the meeting. 

I'll be posting highlights here once the meeting concludes.

Dee
Every Day is a Blessing! 



Posted by at No comments:
Labels: , , , ,

Tuesday, March 22, 2022

Planning My SGO 2022 Meeting Posts, Observations and Thank you's


 

I am back from my first ever, in-person SGO 2022 Annual Meeting. This meeting was solely gynecologic cancer research but covered a range of topics - from mouse studies to the use of FDA approved drugs , from disparities in treatment of endometrial cancer to the impact of  packaging's impact on financial toxicity. And in my opinion each and every study was valuable. I will report on these topics over the next few days.

Rare Gyn Cancers
Disparities and Equity Research Across Gyn Cancers 
Ovarian Cancer
Endometrial Cancer 
Cervical Cancer
 
Making connections and reconnecting at meetings is an important part of the in-person meeting. For example,  I had a chance to chat with Dr Fiona Simpkins and Dr Sarah Adams. A few years ago, while I was on the Board of the Kaleidoscope of Hope Ovarian Cancer Foundation, these gyn oncs received grants from the Foundation. Seeing them present their research and lead sessions at a national meeting made me smile. To all the foundations raising funds to support ovarian cancer research,  your grants are making a significant difference in the careers of the scientists you support. Please continue your support.

I would like to thank Annie Ellis, survivor and advocate extraordinaire, for her guidance about attending the meeting in person and for gathering advocates and patients attending the meeting so that we could network with each other. I also want to thank the SGO President, Dr Yamada and Meeting Chairs, Dr Adams ( yes the same Dr Adams supported by the KOH grant)  and Dr Nickles Fader for the outstanding meeting and for including patients / advocates on panels.  And finally thank you to each and every gyn cancer researcher, fellow and resident for the work you do.

Stay tuned for my meeting blog posts. 
 
Dee
Every Day is a Blessing! 

Posted by at No comments:
Labels: , , , ,

Friday, March 11, 2022

Building Bridges, Breaking Barriers - SGO Annual Meeting

740.jpg

 

For the first time in over two years, I will be attending an in-person conference as a patient advocate next week. I am excited to be attending the  SGO Annual Meeting which will be a hybrid meeting in Phoenix Arizona, March 18th to the 21st. The theme Building Bridges, Breaking Barriers is reflected in the topics of the scheduled master classes, wellness curriculum, plenary sessions, forums and poster sessions. You may learn more about the meeting at  https://www.sgo.org/events/annual-meeting/.  Cancer survivors and patient advocates who would like to attend the meeting should reach out to meetings@sgo.org for registration information.

My top picks for sessions to attend include:

Breaking Barriers: Towards Greater Equity in Gyn Oncology Care
Breaking Barriers: Pioneering Protocols and Scientific Progress
Building the Bridge Between Bench and Beside/ Inequities During the Pandemic and Beyond 
Novel Therapeutics
Palliative Care: Difficult Diagnosis
Industry Sponsored Session-  Managing Ovarian Cancer

The Presidential Address by Diane Yamada, MD,  the Conversation with SGO Past Presidents as well as the invited Guest Speaker Martin Makary, MD, MPH will be must see sessions for me too.
 
My plan is to tweet live using the hashtag #SGOmtg and #gyncsm. I'll follow up after the meeting with a few posts on this blog.

I am look forward to meeting with other gynecologic cancer advocates at the meeting. Are you attending in-person or virtually? If you are, let me know by commenting below, tagging me in a  tweet ( @womenofteal) or email me. 

Dee 
Every Day is a Blessing! 


Posted by at No comments:
Labels: , , ,

Wednesday, March 24, 2021

2021 SGO Virtual Meeting Sunday March 21, 2021

I am happy to share with you Tweets that cover the work presented during the last full day session of SGO was on Sunday, March 21, 2021.

One session, Time to Return to the Drawing Board, reported clinical trial results that did not meet their aims. Understanding where a drug or treatment may have failed to provide the results expected is as important as those trials that meet aims.

 Atezolizumab

Falretuzumab

 

Durvalumab and Trememlimumab

Additional sessions of interest.

Barriers to Quality of Care - Poster 

Uterine lavage and early detection

Post operative opiods use model 

Neuropathy and genetic variants 

Gross resection and OS / NACT

Vulvar Cancer Studies 

Endometrial cancer 

Cediranib and Olaparib NRG GY012

IUD

 Enzalutamide


Here are some articles from various sources that go more into depth about studies discussed at the meeting. 

Medscape article on hormone IUD and endometrial cancer https://www.medpagetoday.com/meetingcoverage/sgo/91740

Vulvar cancer patients with sentinel node micrometastases, radiation therapy (RT) to the groin after local excision led to extremely low rates of recurrence, a phase II trial suggested https://www.medpagetoday.com/meetingcoverage/sgo/86603 

ABV-500 small molecule in OC https://www.medpagetoday.com/meetingcoverage/sgo/91739

 

Thank you so Eisai for supporting patient advocates at the annual meeting . 

Thank you SGO leadership for making us feel welcome and for all the gyn oncs who answered our questions.  

Dee

Every Day is a Blessing!

Posted by at No comments:
Labels: , , , , , , , , , , , ,

Sunday, March 17, 2019

SGO Annual Meeting - Saturday 3/16

Saturday SGO Meeting:

I wish I had been able to hear the SGO Presidential speech by Dr. Agnes Binagwaho (@agnesbinagwaho) .



Financial Toxicity



Genetic Testing
PARP Inhibitors


Cancer Disparity

Leadership - Dr Parkham Zambia


Thank you Yvette WilliamsBrown (@MYvetteWB), Ali Saiz, MD (@AllisonSaizMD), Shannon Westin (@ShannonWestin), Ross Harrison (@RossFH), Erin Stevens (@erinstevensmd), BJ Rimel (@BJRimelMD) and Annie Ellis (@Stigetta) for taking the time to tweet from the meeting.

Dee
Every Day is a Blessing!
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)